• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Beam-linked startup launches with an eye on the next generation of RNA drugs

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 07, 2022 at 10:52: AM
via Orbital Therapeutics, a Cambridge, Mass.-based biotechnology startup focused on RNA-based medicines, launched Wednesday with a research collaboration with gene editing company Beam Therapeutics.

article source
 




Top Bottom
Back
Quote